By Sally Robertson, B.Sc. May 20 2021 Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19). The team – from the University of Liverpool and the MRC Laboratory of...
